A New Kind Of Drug For Approved For Schizophrenia Promises Fewer Side Effects

Washington: For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia.

The twice-a-day pill to be marketed by Bristol Myers Squibb will be called Cobenfy, though it had been referred to as KarXT during development. Its main advantage is that it appears to have fewer side effects than current medicines.

That difference has captured the attention of patients like Tiffany, a librarian in Oklahoma. She asked us to use only her first name because of the stigma associated with schizophrenia.

When she was first put on an antipsychotic drug, she says it made her feel like a zombie. Watching a video of her birthday party that year, she didn’t recognize herself.

“I was opening presents — everyone was happy. And I’m just sitting there like, there’s nothing going on. Like, I’m staring at a blank wall,” she says. “And so I lied and I told everyone I was better.”

Related Posts

  • Pharma
  • July 8, 2025
  • 28 views
‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

As it turns 3, New American Kid on the Block strikes gold Delhi NCR:  AACI (American Accreditation Commission International) took such giant strides in India in just three years as…

  • Pharma
  • July 5, 2025
  • 208 views
Traditional medicine crucial to achieving global goals of Universal Health Coverage

Global goals like Universal Health Coverage (UHC) can only be met when traditional medicine becomes an essential part of the national health policy and wellness delivery, said Dr. Kashinath Samagandi,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

Traditional medicine crucial to achieving global goals of Universal Health Coverage

Traditional medicine crucial to achieving global goals of Universal Health Coverage

Lupin launches Ipratropium Bromide nasal spray in US

Lupin launches Ipratropium Bromide nasal spray in US

Surgical Robot MantraM, First ‘Badge of Vishwaguru’ is on Triumphal March

Surgical Robot MantraM, First ‘Badge of Vishwaguru’ is on Triumphal March